Vigonvita Life Sciences
33
6
6
25
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 33 trials
100.0%
+13.5% vs industry average
9%
3 trials in Phase 3/4
0%
0 of 25 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (33)
Study of Food Effects of VV913 Capsules in Chinese Healthy Volunteers
Role: lead
Study of the Safety, Tolerability, Pharmacokinetics of VV913 Capsules in Chinese Healthy Participants
Role: lead
Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119
Role: lead
Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV913 Capsules
Role: lead
Study of the Safety, Tolerability, Pharmacokinetics of VV261 Tablets in Chinese Healthy Volunteers
Role: lead
Study of Food Effects of VV119 Capsules in Chinese Healthy Volunteers
Role: lead
Study of the Safety, Tolerability, and Pharmacokinetics of LV232 Capsules in Chinese Healthy Volunteers
Role: lead
Safety and Pharmacokinetics Study of Multiple Ascending Doses and Food Effect of LV232 Capsules
Role: lead
A Study to Evaluate the Bioavailability of Two Specifications of Oral Deuremidevir Hydrobromide for Suspension
Role: lead
Long-term Safety of TPN171H Tablet in Erectile Dysfunction.
Role: lead
A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV
Role: lead
Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers
Role: lead
A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET
Role: lead
Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD
Role: lead
A Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients with Renal Insufficiency and Healthy Subjects
Role: lead
Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial Hypertension
Role: lead
A Study to Evaluate the Bioavailability, Food Effect and Pharmacokinetics of Deuremidevir Hydrobromide for Suspension
Role: lead
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Deuremidevir Hydrobromide for Suspension
Role: lead
Drug-Drug Interaction (DDI) Study for TPN171H
Role: lead
Safety and Pharmacokinetics of a Single Oral TPN171H in Healthy Elderly Subjects
Role: lead